Davenport & Co’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-60,100
Closed -$412K 716
2017
Q3
$412K Buy
60,100
+22,000
+58% +$139K 0.01% 478
2017
Q2
$251K Sell
38,100
-5,200
-12% -$36.4K ﹤0.01% 575
2017
Q1
$403K Hold
43,300
0.01% 443
2016
Q4
$402K Sell
43,300
-25,200
-37% -$261K 0.01% 447
2016
Q3
$725K Sell
68,500
-7,500
-10% -$74.7K 0.01% 348
2016
Q2
$710K Buy
76,000
+39,000
+105% +$396K 0.01% 345
2016
Q1
$384K Buy
37,000
+22,200
+150% +$203K 0.01% 413
2015
Q4
$149K Buy
+14,800
New +$148K ﹤0.01% 551
2015
Q2
Sell
-46,100
Closed -$653K 620
2015
Q1
$653K Sell
46,100
-27,850
-38% -$362K 0.01% 347
2014
Q4
$739K Sell
73,950
-60,100
-45% -$514K 0.01% 321
2014
Q3
$1.14M Sell
134,050
-3,250
-2% -$28.6K 0.02% 261
2014
Q2
$1.21M Buy
137,300
+9,600
+8% +$83.8K 0.02% 249
2014
Q1
$1.19M Buy
+127,700
New +$1.12M 0.02% 246

Other funds holding OPK

Davenport & Co's OPK Position: Q4 2017 in Review

Davenport & Co sold out of Opko Health (OPK) in Q4 2017, closing a stake of 60,100 shares — an estimated $412K sold.

Davenport & Co first reported a position in OPK in Q1 2014 and held it in 13 quarters. The position peaked at $1.21M in Q2 2014. 231 funds tracked by Wall St. Rank hold OPK as of Q4 2017.

  • Davenport & Co reported no remaining Opko Health position as of Q4 2017 after selling out during the quarter.
  • Davenport & Co sold 60,100 Opko Health shares in Q4 2017, an estimated $412K.
  • Davenport & Co first reported a position in Opko Health in Q1 2014 and held it in 13 quarters.
  • Davenport & Co's Opko Health position peaked at $1.21M in Q2 2014.
  • 231 funds tracked by Wall St. Rank held Opko Health as of Q4 2017.

Based on Davenport & Co's 13F filing for Q4 2017, filed 17 Jan 2018.